The World Health Organization has listed two more mpox in vitro diagnostics under its Emergency Use Listing (EUL) procedure. The Xpert Mpox test is designed for use on compatible GeneXpert systems. The cobas MPXV assay, developed by Roche Molecular Systems, Inc., is a real-time PCR test capable of detecting both mpox clades. WHO is working with manufacturers of the EUL-listed products and national regulatory authorities in affected countries to facilitate domestic registration or emergency listing. The WHO EUL is a risk-benefit assessment designed to meet urgent needs during public health emergencies based on limited available data.